Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Translational Oncology|July 1, 2017
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant ChemotherapyEleni Timotheadou, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.
Cancer Genomics & Proteomics|October 22, 2018
Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with TrastuzumabChristos Christodoulou, Georgios Oikonomopoulos, Georgia Angeliki Koliou, et al.
Plos One|September 30, 2016
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesVassiliki Kotoula, Sotiris Lakis, Ioannis S Vlachos, et al.
Anticancer Research|April 4, 2021
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast CancerGeorgios Rigakos, Evangelia Razis, Georgia-Angeliki Koliou, et al.
Plos One|May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trialGeorge Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Frontiers in Oncology|February 2, 2013
Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaNikolaos Charalambakis, Vassilis Kouloulias, Helena Vaja, et al.
Clinical Breast Cancer|September 6, 2017
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III TrialsAnna Batistatou, Vassiliki Kotoula, Mattheos Bobos, et al.
Plos One|March 29, 2013
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer casesAlexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, et al.
Breast Cancer Research and Treatment|July 3, 2016
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytesVassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, et al.
Pageof 19